Objective: To establish the reproducibility of a published observation by Lubetzky et al. that infants affected by retinopathy of prematurity (ROP) had higher absolute nucleated red blood cell (aNRBC) counts than those unaffected. The authors suggested that infants exposed to intrauterine hypoxia are at higher risk for ROP. We attempted to verify this reported relationship of ROP with the aNRBCs at birth and hypothesized that infants with ROPX stage 2 have higher aNRBCs at birth.
Introduction
Retinopathy of prematurity (ROP) is a developmental disorder of retinal vascularization most commonly in very low birth weight (BW) infants (<1500 g BW).
1,2 Neonatal intensive care has led to an increased survival of these at risk infants over the past 30 years and, subsequently, to an increasing incidence of ROP.
Retinal vascularization begins by 15 to 18 weeks and is completed by 40 weeks. Injury to newly formed blood vessels by hypotension, hypoxia, hyperoxia or free radicals, disrupts growth and causes increased vascular permeability, retinal edema and hemorrhage. Abnormal fibrovascular tissue may develop along with neovascularization. Contraction of the fibrovascular tissue produces traction on the retina, leading to retinal distortion and detachment. 3 The cause of ROP is not clear, but most experts agree it is multifactorial. Prematurity, low BW, prolonged assisted ventilation, elevated arterial oxygen tension (>80 mm Hg), high blood transfusion volume, cumulative illness severity, sepsis, intraventricular hemorrhage, brochopulmonary dysplasia, systemic fungal infections, longitudinal weight gain and serum concentrations of IGF-1 and IGF-BP3 are all associated with ROP. [4] [5] [6] [7] Lubetzky et al. evaluated 23 infants with ROP in a case matched analysis and found an elevation of aNRBC counts in those who subsequently developed ROP. The authors speculated on the mechanism by which ROP was associated with increased circulating neonatal absolute nucleated red blood cell (aNRBC) counts as relative fetal hypoxia. In favor of a contribution of fetal hypoxia/ischemia in the pathogenesis of ROP is the increased rate of ROP in conditions such as fetal growth restriction and severe neonatal asphyxia, both known to potentially compromise retinal blood flow and/or oxygen supply. Two pathogenic mechanisms were proposed, a hypoxic induced increase in vascular endothelial growth factor, which would stimulate neovascularization and a hypoxic induced increase of insulin-like growth factor-binding protein-1, which may prevent normal vessel growth by reducing free insulin-like growth factor. The associated hypoxia would also induce fetal erythropoietin stimulating aNRBCs to be released into the circulation. [8] [9] [10] [11] [12] The previous retrospective work supports the theory that longstanding fetal hypoxia and/or ischemia may have a role in the pathogenesis of ROP. Our goal was to test this association of elevated aNRBCs and the development of ROP in a case-matched, larger cohort. We hypothesize that infants who develop ROP have higher aNRBC counts than matched controls.
Several process level interventions have been introduced in our Neonatal Intensive Care Unit (NICU) to maintain a low ROP rate relative to the national average; however, there are still cases that lead to significant visual impairment. If the previous observation is substantiated, we may be able to prospectively identify infants at higher risk for ROP and alter their care to prevent ROP. In addition, these data would support the design of a prospective evaluation of the biochemical markers of intrauterine hypoxia, vascular endothelial growth factor and insulin-like growth factor binding protein-1.
Methods

Research design
Using our clinical data warehouse, we searched from 1st January 2000 to 31st December 2008 for infants with a BW between 501 and 1500 g and having a diagnosis from the ROP family (ROP: ruled out, at risk for, stage 0 to IV). We excluded infants who died, were acutely transferred in the first 28 days, those who were small for gestational age (GA) or who had a congenital anomaly. Within this group of qualified patients we identified all infants who had ROP of stage II or higher in any zone. We then randomly selected a match from the remaining infants matching BW ±100 g and GA (same week) to maximize total evaluable infants. Clinical characteristics, laboratory evaluations and outcomes were extracted for analysis (see Figure 1 ).
Sample size justification
Because of its retrospective nature, the sample size was determined by the availability of subjects within the database (convenience sample) for the time periods described.
Hematological methods
All preterm infants admitted to the NICU undergo a routine complete blood count with manually counted differential and an aNRBC count from a capillary sample. The laboratory equipment and methods did not change over the course of the data sample.
Confounding conditions
We extracted several confounding infant and maternal diagnosis including but not limited to gestational or insulin-dependent diabetes, pregnancy-induced hypertension, placental abruption, placenta previa, any maternal drug, tobacco or alcohol abuse, clinical signs of chorioamnionitis, non-reassuring fetal heart tones or low (<6 at 1 or 5 min) Apgar scores.
Retinopathy evaluation
Between 1st January 2000 and 31st December 2008 a strict protocol of ROP screening consistent with the 2001 American Academy of Pediatrics Guidelines was followed. 13, 14 All infants with a BW of <1500 g or a GA of <28 weeks underwent a dilated eye exam with the indirect ophthalmoscope to detect ROP.
Statistical analysis
Statistical Package for the Social Sciences (SPSS) 17.0 was used for all analysis. The analytical plan included specific comparisons of demographic characteristics to demonstrate similarity between the ROP affected and control infant populations. Continuous data tested by non-parametric testing (Wilcoxon's sign rank) and categorical data by w 2 contingency table analysis. P<0.05 was considered significant.
Results
We identified 66 matched pairs. As expected the matched variables GA and BW, as well as demographic variables, gender and race, were not significantly different ( Table 1) . The groups were balanced in delivery mode, multiple gestations, surfactant exposure and the presence of RDS (Table 2 ). There was an increase in periventricular leukomalacia and severe intraventricular hemorrhage in the ROP group, as reported by others as a reflection of severity of illness, but in this sample it was not statistically significant ( Table 2) .
The aNRBCs were 5287±6524 for unaffected versus 4550 ± 7342 for the ROP affected group (P ¼ 0.79). The distribution of aNRBC by severity of ROP is presented (Figure 2) . In our population, there was no relationship between aNRBCs at birth and the development of severe ROP.
Discussion and conclusion
Although a single retrospective analysis noted a link between nucleated RBC counts and ROP, suggesting long standing Figure 1 Study-subject selection from the clinical data warehouse.
aNRBC and retinopathy are not related S Gotru et al intrauterine hypoxia predisposed infants to ROP, we are unable to support this observation. Our population was three times larger, ROP rates were lower than those reported in the previous study and we had several infants with aNRBC counts much higher than the original report. The matching process balanced demographics and early illness. In spite of these factors, we could not find any relationship of the aNRBC counts at birth and the development of severe ROP. A predisposition to ROP, as reflected in the aNRBC count, should have been easier for us to demonstrate if it exists. Alternative care for this subgroup of at risk infants might be indicated if this relationship could be confirmed in an even larger retrospective cohort. aNRBC and retinopathy are not related S Gotru et al
